Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
credit: University of Oxford/David Fisher

The Genomic Medicine and Statistics Programme

GMS is a four-year doctoral training programme at the University of Oxford, established in 2008. Our goal is to train future leaders in the application of genomics to advance human health, equipping them with skills sets spanning experimental and analytical genomic science to address current roadblocks by innovating and realising the potential of genomics.

We will recruit students from diverse backgrounds with a track record of academic excellence and enthusiasm for this field. The first year will provide necessary core skills through taught modules with a minimum of two three-month rotations to gain exposure and training in different research environments prior to deciding on the topic of doctoral research.

The GMS programme 2020 will be supported by an outstanding group of supervisors active in cutting-edge inter-disciplinary research to deliver research training, teaching and mentorship across the breadth of genomic medicine and statistics, enabling us to deliver on our vision to train a cohort of future leaders and innovators in genomics and its application.

The research of our supervisors encompasses the following themes:

  • Genomic and -omic technologies (including method development, single cell genomics, imaging, model systems, CRISPR screens, genome engineering; proteomics, metabolomics, high throughput screening)
  • Functional genomics (gene regulation and epigenetics)
  • Genome biology (genetic variation, recombination, human history, evolution, palaeogenomics, pathogen genomes)
  • Genomics of disease (Mendelian, multifactorial traits, cancer)
  • Genomic analysis (bioinformatics and statistical genetics)
  • From genes to clinical proof of concept (integrated drug development pipeline spanning genetic-led target discovery, structural biology, medicinal chemistry)
  • Application of genomics in the clinic (rare disease diagnostics, cancer therapeutics, personalised medicine and genome therapies)

The course director is Julian Knight, Professor of Genomic Medicine at the University of Oxford and Tutorial Fellow at Merton College. The co-directors are John Todd, Director of the Wellcome Centre for Human Genetics , and Cath Green

For more information, and to apply, see the Medical Sciences Division website.